These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21492498)

  • 81. Lack of clinically useful response predictors for treating aggression and agitation in Alzheimer's disease with citalopram.
    Herrmann N
    Evid Based Ment Health; 2016 Nov; 19(4):e24. PubMed ID: 27613071
    [No Abstract]   [Full Text] [Related]  

  • 82. Commentary on "When and How to Treat Agitation in Alzheimer's Disease Dementia With Citalopram and Escitalopram".
    Pollock BG
    Am J Geriatr Psychiatry; 2019 Oct; 27(10):1108-1109. PubMed ID: 31208921
    [No Abstract]   [Full Text] [Related]  

  • 83. [Suggestions Obtained from the J-CATIA Study (Japan Consortium for Antipsychotics Treatment in Alzheimer's Disease)].
    Arai H
    Seishin Shinkeigaku Zasshi; 2016; 118(11):845-848. PubMed ID: 30620841
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Risperidone in Elderly Schizophrenic Patients: An Open-Label Trial.
    Berman I; Merson A; Rachov-Pavlov J; Allan E; Davidson M; Losonczy MF
    Am J Geriatr Psychiatry; 1996 Spring; 4(2):173-179. PubMed ID: 28531009
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Pimavanserin for patients with Alzheimer's disease psychosis.
    Schneider LS
    Lancet Neurol; 2018 Mar; 17(3):194-195. PubMed ID: 29452674
    [No Abstract]   [Full Text] [Related]  

  • 86. Escitalopram for repeated stealing in an elderly man with an existing cerebral contusion.
    Mori Y; Ochiai S
    Psychogeriatrics; 2022 Mar; 22(2):281-283. PubMed ID: 34951082
    [No Abstract]   [Full Text] [Related]  

  • 87. Peripheral Edema Occurring during Treatment with Risperidone Combined with Citalopram.
    Hosseini SH; Ahmadi A
    Case Rep Med; 2012; 2012():540732. PubMed ID: 23251178
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Acute oedema associated with risperidone use: a report.
    Thakur A; Niranjan V; Rastogi P; Razdan R
    Gen Psychiatr; 2020; 33(4):e100203. PubMed ID: 32656495
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Citalopram and escitalopram: adverse cardiac outcomes in medically ill inpatients.
    Elie D; Noohi S; Do A; Mahdanian A; Yu C; Segal M; Looper KJ; Rej S
    Ther Adv Drug Saf; 2016 Oct; 7(5):225-226. PubMed ID: 27695624
    [No Abstract]   [Full Text] [Related]  

  • 90. Escitalopram-induced extrapyramidal symptoms.
    Kumar PNS; Krishnan AG; Suresh R
    Indian J Psychiatry; 2019; 61(3):318-319. PubMed ID: 31142916
    [No Abstract]   [Full Text] [Related]  

  • 91. Hypothermia in a patient with Alzheimer's disease receiving a combination therapy with risperidone and pipamperone.
    Kamp D; Paschali M; Supprian T; Lange-Asschenfeldt C
    Ther Adv Psychopharmacol; 2016 Feb; 6(1):55-7. PubMed ID: 26913178
    [No Abstract]   [Full Text] [Related]  

  • 92. Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial.
    Porsteinsson AP; Drye LT; Pollock BG; Devanand DP; Frangakis C; Ismail Z; Marano C; Meinert CL; Mintzer JE; Munro CA; Pelton G; Rabins PV; Rosenberg PB; Schneider LS; Shade DM; Weintraub D; Yesavage J; Lyketsos CG;
    JAMA; 2014 Feb; 311(7):682-91. PubMed ID: 24549548
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Citalopram for agitation in Alzheimer's disease: design and methods.
    Drye LT; Ismail Z; Porsteinsson AP; Rosenberg PB; Weintraub D; Marano C; Pelton G; Frangakis C; Rabins PV; Munro CA; Meinert CL; Devanand DP; Yesavage J; Mintzer JE; Schneider LS; Pollock BG; Lyketsos CG;
    Alzheimers Dement; 2012; 8(2):121-30. PubMed ID: 22301195
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Agitation and aggression in people with Alzheimer's disease.
    Ballard C; Corbett A
    Curr Opin Psychiatry; 2013 May; 26(3):252-9. PubMed ID: 23528917
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review.
    Seitz DP; Gill SS; Herrmann N; Brisbin S; Rapoport MJ; Rines J; Wilson K; Le Clair K; Conn DK
    Int Psychogeriatr; 2013 Feb; 25(2):185-203. PubMed ID: 23083438
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Discontinuation of antidepressants in people with dementia and neuropsychiatric symptoms (DESEP study): double blind, randomised, parallel group, placebo controlled trial.
    Bergh S; Selbæk G; Engedal K
    BMJ; 2012 Mar; 344():e1566. PubMed ID: 22408266
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.
    Maust DT; Kim HM; Seyfried LS; Chiang C; Kavanagh J; Schneider LS; Kales HC
    JAMA Psychiatry; 2015 May; 72(5):438-45. PubMed ID: 25786075
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Role of citalopram in the treatment of agitation in Alzheimer's disease.
    Porsteinsson AP; Keltz MA; Smith JS
    Neurodegener Dis Manag; 2014; 4(5):345-9. PubMed ID: 25405648
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Galantamine versus risperidone for agitation in people with dementia: a randomized, twelve-week, single-center study.
    Freund-Levi Y; Bloniecki V; Auestad B; Tysen Bäckström AC; Lärksäter M; Aarsland D
    Dement Geriatr Cogn Disord; 2014; 38(3-4):234-44. PubMed ID: 24969380
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Can antidepressant medication relieve agitation in Alzheimer's disease?
    Porsteinsson AP; Smith JS; Keltz MA; Antonsdottir IM
    Expert Rev Neurother; 2014 Sep; 14(9):969-71. PubMed ID: 25148535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.